Model 1
|
A
|
Relative intensity of apoA-I glycation
|
0.589
|
0.407 ± 0.004
|
< 0.001
|
0.636
|
0.483 ± 0.022
|
< 0.001
|
HDL-associated PON1 activity
| |
−0.439 ± 0.000
|
< 0.001
| |
−0.302 ± 0.002
|
< 0.001
|
B
|
Relative intensity of apoA-I glycation
|
0.627
|
0.760 ± 0.007
|
< 0.001
|
0.645
|
0.666 ± 0.039
|
< 0.001
|
HDL-associated PON1 activity
| |
0.207 ± 0.001
|
0.179
| |
0.033 ± 0.004
|
0.827
|
*Interaction
| |
−0.603 ± 0.000
|
< 0.001
| |
−0.312 ± 0.001
|
0.019
|
Model 1
|
A
|
Relative intensity of apoA-I glycation
|
0.541
|
0.395 ± 0.005
|
< 0.001
|
0.634
|
0.448 ± 0.023
|
< 0.001
|
HDL-associated PON3 activity
| |
−0.383 ± 0.000
|
< 0.001
| |
−0.320 ± 0.002
|
< 0.001
|
B
|
Relative intensity of apoA-I glycation
|
0.558
|
0.623 ± 0.008
|
< 0.001
|
0.658
|
0.707 ± 0.037
|
< 0.001
|
HDL-associated PON3 activity
| |
0.116 ± 0.001
|
0.523
| |
0.247 ± 0.06
|
0.124
|
*Interaction
| |
−0.441 ± 0.000
|
0.004
| |
−0.500 ± 0.001
|
< 0.001
|